Who should attend?
  • Hospital Consultants
  • SpRs
  • Associate Specialists and Specialist Trainees with an interest in Cardiovascular disease
  • Caring Professionals
  • Chemical Pathologists
  • Clinical Lipidologists
  • Diabetologists
  • ​Geneticists
  • Cardiologists
  • Vascular Surgeons
  • Cardiovascular Radiologists
  • Allied Health Professionals
  • Community Pharmacists
  • General Practitioners
  • GPs with Specialist Interest in CVD
  • Physicians
  • Directors of Public Health
  • Healthcare Commissioners
  • Nurses - Specialist Cardiovascular and Lipid Clinic
  • Nurses - Practice
  • Nurses - Genetics Specialist
  • Dietitians
  • Nutritionists
  • Basic Scientists
  • Scientists and researchers in cardiovascular diseases
  • Those with an interest in cardiovascular disease, lipids and atherosclerosis

Abstracts of Free Communications
– Oral Sessions

Friday 6 July 2018
11:00 - 12:15


There are two sessions of oral free communications on Friday afternoon which will run in parallel in both the Medical & Scientific and Primary & Health Care programmes.

Each session will comprise of 5 abstracts each giving a 10 minute oral presentation followed by 5 minutes of questions.

Medical & Scientific Abstracts

1/
HIGH RATES OF NON-ADHERENCE TO ANTIDIABETIC, ANTIHYPERTENSIVE AND LIPID LOWERING TREATMENT IN PATIENTS WITH TYPE 2 DIABETES REVEALED LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (LC-MS/MS) URINE ANALYSIS
Gupta P1,2, Mohamed AA1, Patel P1, Burns A1, Saeed M1, Lane D1, Seidu S3,4 and  Khunti K3,4
1Department of Metabolic Medicine and Chemical Pathology, University Hospitals of Leicester NHS Trust, UK
2Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
3Leicester Diabetes Centre, Leicester General Hospital, Leicester, UK
4Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK

2/
CAN MONOGENIC SEVERE HYPERTRIGLYCERIDEMIA BE DIFFERENTIATED FROM POLYGENIC FORMS THROUGH CLINICAL FEATURES: DATA FROM APPROACH AND COMPASS STUDIES IN FCS AND NON-FCS HYPERTRIGLYCERIDEMIC PATIENTS?
Louis O’Dea1, James MacDougall2, Andres Digenio, Brant Hubbard1, Marcello Arca3, Patrick Moriarty4, John Kastelein5, Eric Bruckert6, Handrean Soran*7
1AkceaTherapeutic Inc., Cambridge, MA, USA; 2BioBridges, Wellsley, MA, USA; 3Department of Internal Medicine and Allied Sciences, La Sapienza University of Rome, Rome, Italy; 4Department of medicine, Division of Clinical pharmacology, University of Kansas Medical Center, Kansas City, Kansas; 5Department of Vascular Medicine, Academic Medical Center (AMC), University of Amsterdam, Amsterdam, Netherlands; 6Institut E3M et IHU Cardiométabolique (ICAN), Hôpital Pitié-Salpêtrière, Paris, France; 7Manchester University Hospital NHS Trust, Manchester, UK

3/
PROTEIN STRUCTURE ANALYSIS AIDS IN THE INTERPRETATION OF GENETIC VARIANTS OF UNCERTAIN CLINICAL SIGNIFICANCE IDENTIFIED IN THE LDL RECEPTOR

A. David1, S. Ittisoponpisan1, M.J.E. Sternberg1
Centre for Structural Biology, Department of Life Sciences, Imperial College London, London, UK

4/
CORONARY HEART DISEASE MORTALITY IN SEVERE AND NON-SEVERE FAMILIAL HYPERCHOLESTEROLAEMIA: DATA FROM THE UK SIMON BROOME FH REGISTER
S.E. Humphries1*, J.A. Cooper1, M. Seed2, N. Capps3, P.N. Durrington4, B. Jones5, I.F.W. McDowell6, H. Soran7, H.A.W. Neil8 on behalf of the Simon Broome FH Register Group
1Cardiovascular Genetics, UCL, London, 2Cardiology, Charing Cross Hospital, U of London; 3Clinical Biochemistry, Princess Royal Hospital, Telford; 4Cardiovascular Research Group, U of Manchester; 5Investigative Medicine, Imperial College London, 6Medical Biochemistry and Immunology, U Hospital of Wales, Cardiff; 7Central Manchester University Hospitals, Manchester; 8Wolfson College, University of Oxford, UK           

5/
AUTOSOMAL RECESSIVE HYPERCHOLESTEROLAEMIA DUE TO HOMOZYGOUS LDLRAP1 VARIANTS: A BRISTOL CASE REVIEW

Honeychurch J*1, Hills A1, Watson E1, Pennock M1, Dent C, Evans J, Robinson C, Woodward G1, Wadsley M1, Morris A2, Cramb, R3, Dawson C3, Soran H4, Nicholson K4, Williams M1
1 Bristol Genetics Laboratory, Bristol, UK
2 Alder Hey Children’s Hospital, Liverpool UK
3 New Queen Elizabeth Hospital, Birmingham, UK
4 Old Saint Mary’s Hospital, Manchester, U   

Primary & Health Care Abstracts

6/
COST-EFFECTIVENESS OF UNIVERSAL SCREENING FOR FAMILIAL HYPERCHOLESTEROLAEMIA (FH) AT AGE 1-2 YEARS

A.J. McKay1, H. Hogan2, S.E. Humphries3*, D. Marks4, K.K. Ray5, A. Miners
1London School of Hygiene and Tropical Medicine (LSHTM), London, UK; 2Department of Health Services Research and Policy, LSHTM, UK; 3Cardiovascular Genetics, UCL, UK; 4Department of Public Health, Environments and Society, LSHTM, UK; 5Department of Primary Care and Public Health, Imperial College London, UK.

7/
FAMILIAL HYPERCHOLESTEROLAEMIA IN THE GENOMIC ERA: IMPROVING THE CLINICAL UTILITY OF CURRENT GENETIC
TESTING
Knowles C1*, Hills A1, Watson E1, Pennock M1, Dent C1, Evans J1, Robinson C1, Woodward G1, Wadsley M1, Honeychurch J1, Williams M1
1 Bristol Genetics Laboratory, Bristol, UK

8/
FAMILIAL HYPERCHOLESTEROLAEMIA (FH) GENETIC TESTING IN THE UK

Haralambos K1*, Humphries SE2, Whitmore J3, Datta D4, Cather M5, Miedzybrodzka Z6,  Breen J7, Gritzmacher L8, Hamlen A9, Potter A10, Cazeaux A11, Sherman C11, Moore A12, Tyler M12, Burton C13, Webster J13, Tuson C13, Sutton P13, Dunn R13, Nicholson K14, Harvey D15, Jayne Z15, Maughan D16 , McDowell IFW1
1Cardiff University, 2Institute Cardiovascular Sciences, London, 3British Heart Foundation, 4All Wales FH Cascade Testing Service, 5Northern Ireland FH Service, 6Scottish FH Service, 7Harefield, London FH Service, 8Bristol and Bath FH Service, 9Gloucestershire FH Service, 10North East England FH Service, 11Wessex FH Service, 12South Yorkshire & North Derbyshire FH Service, 13Yorkshire & Humber FH Service, 14Manchester FH Service, 15Royal Free FH Service, 16Doncaster FH Service, UK            

9/
WHAT DIETETIC SUPPORT IS AVAILABLE TO PATIENTS IN OUTPATIENT LIPID CLINICS IN THE UK?

Kinnear, F.J.*1, Lithander, F.E.1, Hamilton-Shield, J.P.1, Main, L.2
1NIHR Bristol Biomedical Research Centre (Nutrition theme), Bristol, UK
2HEART UK- The Cholesterol Charity, Maidenhead, UK

10/
CARDIOVASCULAR RISK ASSESSMENT IN PATIENTS ATTENDING A PIONEERING SPECIALIST MULTIDISCIPLINARY NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) CLINIC: A CLINICAL EFFECTIVENESS STUDY

Goyale A 1, Misas MG 2, Roccarina D 2, Tsochatzis E 2 and Nair DR 1
Royal Free London NHS Foundation Trust, London, NW3 2QG
UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London

 

Deadline for abstract submissions: CLOSED

Abstract authors notified of selection: email notification sent 4 April

Deadline for travel grant applications: CLOSED


Prizes and awards will be presented on Friday afternoon, presented by HEART UK’s Medical Director including:

  • Bill Richmond Award for the Best Medical & Scientific Oral Presentation - £400
  • Best Healthcare Oral  Presentation - £400
  • Poster Presentation Prizes - £150 and £75
  • Poster "People's Choice" Prize  -  £100


Link to prize and award information

Abstracts will be judged on timing, presentation, science and questions.

Presented abstracts will be published after the conference on line in Atherosclerosis Supplements.
 

Conference Office

For any questions relating to the Annual Conference, please contact the conference office below:

Natasha Dougall
Wheldon Events & Conferences
93 Watling Street, Bridgtown,
Cannock, Staffordshire WS11 0BG
T: +44 (0) 1543 503 322
F: +44 (0) 1543 466 890
E: wheldonevents@btconnect.com

HUK Conference: Directions

Warwick Arts Centre
University of Warwick, Gibbet Hill Road, Coventry CV4 7AL